180 related articles for article (PubMed ID: 32052730)
1. [Gene therapy for central nervous system disorders].
Nissen K; Klem L; Jeppesen R; Axelsen TM; Christiansen SH; Gøtzsche CR; Pinborg L; Jespersen B; Klemp K; Woldbye D
Ugeskr Laeger; 2020 Jan; 182(3):. PubMed ID: 32052730
[TBL] [Abstract][Full Text] [Related]
2. Lentiviruses as vectors for CNS diseases.
Déglon N; Aebischer P
Curr Top Microbiol Immunol; 2002; 261():191-209. PubMed ID: 11892248
[No Abstract] [Full Text] [Related]
3. Lentivirus-mediated gene transfer to the central nervous system: therapeutic and research applications.
Wong LF; Goodhead L; Prat C; Mitrophanous KA; Kingsman SM; Mazarakis ND
Hum Gene Ther; 2006 Jan; 17(1):1-9. PubMed ID: 16409120
[TBL] [Abstract][Full Text] [Related]
4. [Cell and ex vivo gene therapy: advances in the treatment of central nervous system disorders].
Mejía-Toiber J; Castillo CG; Giordano M
Rev Neurol; 2009 Nov 1-15; 49(9):483-9. PubMed ID: 19859890
[TBL] [Abstract][Full Text] [Related]
5. Use of gene therapy in central nervous system repair.
Tinsley R; Eriksson P
Acta Neurol Scand; 2004 Jan; 109(1):1-8. PubMed ID: 14653844
[TBL] [Abstract][Full Text] [Related]
6. Applications of lentiviral vectors for biology and gene therapy of neurological disorders.
Lundberg C; Björklund T; Carlsson T; Jakobsson J; Hantraye P; Déglon N; Kirik D
Curr Gene Ther; 2008 Dec; 8(6):461-73. PubMed ID: 19075629
[TBL] [Abstract][Full Text] [Related]
7. The use of stem cells in regenerative medicine for Parkinson's and Huntington's Diseases.
Lescaudron L; Naveilhan P; Neveu I
Curr Med Chem; 2012; 19(35):6018-35. PubMed ID: 22963567
[TBL] [Abstract][Full Text] [Related]
8. Lentiviral vectors for treating and modeling human CNS disorders.
Azzouz M; Kingsman SM; Mazarakis ND
J Gene Med; 2004 Sep; 6(9):951-62. PubMed ID: 15352068
[TBL] [Abstract][Full Text] [Related]
9. Clinical gene therapy development for the central nervous system: Candidates and challenges for AAVs.
Leong TW; Pal A; Cai Q; Gao Z; Li X; Bleris L; Hayenga HN; Qin Z
J Control Release; 2023 May; 357():511-530. PubMed ID: 37040842
[TBL] [Abstract][Full Text] [Related]
10. Clinical Gene Therapy for Neurodegenerative Diseases: Past, Present, and Future.
Piguet F; Alves S; Cartier N
Hum Gene Ther; 2017 Nov; 28(11):988-1003. PubMed ID: 29035118
[TBL] [Abstract][Full Text] [Related]
11. Liposomal and viral vectors for gene therapy of the central nervous system.
de Lima MC; da Cruz MT; Cardoso AL; Simoes S; de Almeida LP
Curr Drug Targets CNS Neurol Disord; 2005 Aug; 4(4):453-65. PubMed ID: 16101560
[TBL] [Abstract][Full Text] [Related]
12. Cellular and molecular neurosurgery: pathways from concept to reality--part I: target disorders and concept approaches to gene therapy of the central nervous system.
Zlokovic BV; Apuzzo ML
Neurosurgery; 1997 Apr; 40(4):789-803; discussion 803-4. PubMed ID: 9092853
[TBL] [Abstract][Full Text] [Related]
13. Cell replacement therapies for central nervous system disorders.
Björklund A; Lindvall O
Nat Neurosci; 2000 Jun; 3(6):537-44. PubMed ID: 10816308
[TBL] [Abstract][Full Text] [Related]
14. CNS diseases amenable to gene therapy.
Federoff HJ
Ernst Schering Res Found Workshop; 2003; (43):117-58. PubMed ID: 12894455
[No Abstract] [Full Text] [Related]
15. Presence of tau pathology within foetal neural allografts in patients with Huntington's and Parkinson's disease.
Cisbani G; Maxan A; Kordower JH; Planel E; Freeman TB; Cicchetti F
Brain; 2017 Nov; 140(11):2982-2992. PubMed ID: 29069396
[TBL] [Abstract][Full Text] [Related]
16. Neurodegenerative disorders: Parkinson's disease and Huntington's disease.
Hague SM; Klaffke S; Bandmann O
J Neurol Neurosurg Psychiatry; 2005 Aug; 76(8):1058-63. PubMed ID: 16024878
[TBL] [Abstract][Full Text] [Related]
17. Lentiviral vectors for the central nervous system.
Armandola E
MedGenMed; 2004 Sep; 6(3):17. PubMed ID: 15520640
[No Abstract] [Full Text] [Related]
18. The Challenge of Gene Therapy for Neurological Diseases: Strategies and Tools to Achieve Efficient Delivery to the Central Nervous System.
Piguet F; de Saint Denis T; Audouard E; Beccaria K; André A; Wurtz G; Schatz R; Alves S; Sevin C; Zerah M; Cartier N
Hum Gene Ther; 2021 Apr; 32(7-8):349-374. PubMed ID: 33167739
[TBL] [Abstract][Full Text] [Related]
19. Normal CAG and CCG repeats in the Huntington's disease genes of Parkinson's disease patients.
Rubinsztein DC; Leggo J; Goodburn S; Barton DE; Ferguson-Smith MA
Am J Med Genet; 1995 Apr; 60(2):109-10. PubMed ID: 7485243
[TBL] [Abstract][Full Text] [Related]
20. Gene therapy for misfolding protein diseases of the central nervous system.
San Sebastian W; Samaranch L; Kells AP; Forsayeth J; Bankiewicz KS
Neurotherapeutics; 2013 Jul; 10(3):498-510. PubMed ID: 23700209
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
